Australia's Research and Development Tax Incentive (R&D Tax Incentive) regime can be useful for pre-commercialisation companies serving as a non-dilutive source of funding. Progressing new medical treatments or technologies to market is not a cheap exercise and it can be difficult to secure funding from investors (either debt or equity). Even if a company can secure…